Market News & Trends

10/30/2012

Arthritis Signifies a Vast Untouched Market, Finds Frost & Sullivan Tumor necrosis factor (TNF) inhibitors are currently the only therapeutic class available to psoriatic arthritis…

10/24/2012

Avantor & Rubicon to Collaborate on Next-Generation Functional Excipients   Avantor Performance Materials recently announced it has signed a collaboration agreement with Rubicon Research Private…

10/16/2012

Catalent Licenses Innovative Technology Following a successful research collaboration, Catalent Pharma Solutions recently announced it has taken an exclusive license to innovative taste-masking technology developed…

10/10/2012

Cleveland BioLabs & Incuron Announce Orphan Drug Status Cleveland BioLabs, Inc. and Incuron, LLC, a joint venture between the company and Bioprocess Capital Ventures, recently…